Vyome Holdings, Inc. (HIND) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Vyome Holdings, Inc. (HIND) closed at USD 1.93 on 2026-10-14, a change of -65.1 % over the past year, with a market capitalization of USD 13.41M.

Vyome Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Vyome Holdings, Inc. key figures

Previous close

USD 1.93 (2026-10-14)

1-year change

-65.1 %

Market cap

USD 13.41M

Enterprise value

USD 6.8M

P/E ratio (trailing)

1.10

P/E ratio (forward)

n/a

EPS (trailing)

1.73

EPS (forward)

n/a

PEG ratio

n/a

Price to book

2.22

Revenue growth

-46 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.34

Employees

9

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Vyome Holdings, Inc.

Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Vyome Holdings, Inc. and compare it with other stocks.